LaFleur & Godfrey LLC bought a new stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 25,090 shares of the company's stock, valued at approximately $806,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ashton Thomas Securities LLC acquired a new position in shares of Keurig Dr Pepper during the 3rd quarter worth $25,000. LRI Investments LLC acquired a new position in Keurig Dr Pepper during the 3rd quarter worth $35,000. Hexagon Capital Partners LLC increased its holdings in shares of Keurig Dr Pepper by 105.6% in the 3rd quarter. Hexagon Capital Partners LLC now owns 1,032 shares of the company's stock valued at $39,000 after acquiring an additional 530 shares during the last quarter. Brooklyn Investment Group bought a new position in Keurig Dr Pepper during the 3rd quarter worth $61,000. Finally, Federated Hermes Inc. grew its stake in shares of Keurig Dr Pepper by 21.8% in the second quarter. Federated Hermes Inc. now owns 1,757 shares of the company's stock worth $59,000 after purchasing an additional 314 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Insider Transactions at Keurig Dr Pepper
In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of Keurig Dr Pepper stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $32.65, for a total transaction of $2,252,850,000.00. Following the completion of the transaction, the insider now directly owns 214,443,879 shares of the company's stock, valued at approximately $7,001,592,649.35. This trade represents a 24.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.00% of the company's stock.
Keurig Dr Pepper Trading Up 1.1 %
KDP traded up $0.34 during mid-day trading on Monday, hitting $31.62. 6,930,293 shares of the stock were exchanged, compared to its average volume of 7,931,290. The firm's fifty day moving average is $32.28 and its two-hundred day moving average is $34.20. The company has a market cap of $42.89 billion, a PE ratio of 19.16, a PEG ratio of 2.20 and a beta of 0.62. Keurig Dr Pepper Inc. has a 1-year low of $28.61 and a 1-year high of $38.28. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings results on Thursday, October 24th. The company reported $0.51 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.51. The firm had revenue of $3.89 billion during the quarter, compared to analysts' expectations of $3.92 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The firm's revenue for the quarter was up 2.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.48 earnings per share. Equities analysts forecast that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.
Keurig Dr Pepper Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Friday, January 3rd were given a $0.23 dividend. The ex-dividend date was Friday, January 3rd. This represents a $0.92 annualized dividend and a yield of 2.91%. Keurig Dr Pepper's dividend payout ratio is presently 55.76%.
Analyst Upgrades and Downgrades
KDP has been the subject of a number of research analyst reports. TD Cowen reduced their target price on Keurig Dr Pepper from $39.00 to $36.00 and set a "hold" rating for the company in a report on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft upgraded shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their target price for the company from $37.00 to $39.00 in a research note on Thursday, December 12th. JPMorgan Chase & Co. dropped their price objective on Keurig Dr Pepper from $41.00 to $40.00 and set an "overweight" rating for the company in a report on Friday, October 25th. Royal Bank of Canada boosted their target price on Keurig Dr Pepper from $41.00 to $42.00 and gave the company an "outperform" rating in a research note on Friday, October 25th. Finally, Piper Sandler assumed coverage on Keurig Dr Pepper in a research report on Tuesday, January 7th. They issued a "neutral" rating and a $35.00 price objective for the company. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $37.50.
Check Out Our Latest Stock Analysis on Keurig Dr Pepper
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.